FDA Raises Thyroid Pill Recall to Highest Risk Level
· Telemundo McAllen (KTLM)
The FDA has elevated the risk level of a nationwide recall of thyroid medication to its highest classification, warning that the 'super potent' drug could lead to serious health consequences or death. The recall, issued by Vitruvias Therapeutics Inc. in August, pertains to 30 mg thyroid tablets that may cause hyperthyroidism if taken. The FDA's Class 1 recall indicates a reasonable probability of severe health risks. Patients are advised not to stop taking the medication without consulting their doctor. The affected lot was distributed nationally from January 31, 2025, to September 30, 2025.
AI summary · Source: Telemundo McAllen (KTLM) →
